SMARCB1 and Neoplasm of the lung: Through comprehensive IHC profiling, recurrence of plasmacytic myeloma was ruled out, ultimately leading to the diagnosis of SMARCB1 (INI-1)-deficient intrathoracic neoplasm of the lung.